Sorted By:


ICYMI: Has the 340B Program Lost Its Way?

PhRMA  |  Blog Post

” Rapid growth of contract pharmacy arrangements.

Medicare Monday: A closer look at Part B spending

PhRMA  |  Blog Post

While the Medicare Part B program helps ensure patients can access these complex, innovative medicines, it also works to moderate spending.

Australia’s opportunity to lead the TPP forward

PhRMA  |  Blog Post

But innovative drug-makers are not going to invest in Australia if their discoveries, their IP, are better protected elsewhere; they may not even apply to sell their products there.

Nuevos Informes Destacan el Aumento de la Competencia Global en I + D Biofarmacéutica, Planteando Desafíos Significativos para la Futura Posición de Estados Unidos

PhRMA  |  Press Release

"Si miramos hacia el futuro, vemos que las compañías biofarmacéuticas innovadoras de nuestra nación están comprometidas a asociarse con escuelas de todos los niveles en todo el país para desarrollar la próxima generación de científicos, ingenieros y técnicos que son críticos para avanzar en nuevos tratamientos y curas", añadió la Dra.

Medicare Monday: How Part D helps patients with heart disease live longer, healthier lives

PhRMA  |  Blog Post

We must protect Part D from harmful proposals that could restrict beneficiary access to medicines.

Guess what? Part B drug spending remains stable share of Medicare spending

PhRMA  |  Blog Post

It is also important to note that the Part B program continues to evolve as it is incorporated into innovative payment designs like Accountable Care Organizations and the Oncology Care Model.

Consumers Still Pay Bigger Share For Healthcare Than Government And Businesses

Access Better Coverage  |  From Our Network

And 23% of income for the median household was needed to pay premiums for family coverage in 2013, up from 21% in 2010.

Samantha Budd, PhD

PhRMA  |  Biography

Samantha has a BSc and PhD in Biochemistry from the University of Dundee in Scotland, and conducted research at the Neurosurgery Department, Brigham & Women’s Hospital, Harvard Medical School in Boston, and The Center for Neuroscience Research at The Burnham Institute in San Diego.

Lung-MAP: Personalized Medicine is Driving a New Clinical Research Paradigm

Chartpack  |  From Our Network

Lung-MAP (Lung Cancer Master Protocol) uses genomic profiling to match patients to specific investigational personalized medicines, all under one umbrella study.

Home Page Carousel Test

Access Better Coverage  |  From PhRMA


Medicare Monday: What is ASP?

PhRMA  |  Blog Post

In a future post, we will explore the effect of sequestration, which reduced Medicare reimbursement for Part B covered drugs to ASP+4.3 percent.

Medicare Monday: Billing code basics for biologics in Part B

PhRMA  |  Blog Post

Learn more about Medicare Part B at

Paul Aines

PhRMA  |  Biography

He started his career on the audit staff at professional services company KPMG LLP.

Medicare Monday: Medicare turns 52!

PhRMA  |  Blog Post

In its first 11 years, Part D has: Contributed to decreased mortality rates for seniors each year since its implementation.

Medicare Monday: CMS withdraws Part B demo, takes positive step forward on CMMI

PhRMA  |  Blog Post

Before issuing any new demos, CMMI should carefully consider the feedback received as part of this process.

Why Do Patients Have to Pay Thousands of Dollars in Prescription Medicine Costs Before Coverage Begins?

PhRMA  |  Graphic


Understanding Medicare Part B Pocket Card

PhRMA  |  Report

Medicare Part B covers physician office visits, outpatient care, ambulance services and medical equipment.

Medicare Monday: It is Medicare’s birthday month!

PhRMA  |  Blog Post

We’ve looked at the history of Medicare and broken down the details on our website.

ICYMI: Wall Street Journal and Washington Post Say TPP Should Protect Medical Innovation

PhRMA  |  Blog Post

Any trade deal “has to protect the fruits of innovation in the information economy,” the Journal finishes.

New PwC report finds medicine spending still small share of health spending, concerns may trigger ‘false alarms’

PhRMA  |  Blog Post

” In addition, HRI projects that continued aggressive negotiations by pharmacy benefit managers (PBMs) will further control costs and that when there is competition among medicines in a class, PBMs can negotiate more significant discounts and rebates.

Milliman Report: Reducing Part D Beneficiary Costs through Point-of-Sale Rebates

PhRMA  |  Report

PhRMA engaged Milliman to assess the impact of changing pharmacy and manufacturer rebates to the POS.

Negotiators Must Say “Aloha” to a 21st Century Trade Deal

PhRMA  |  Blog Post

As negotiators embark upon this pivotal week, they must keep in mind the role innovation will play in the future global economy.

Many Patients with Exchange Coverage to Pay More than Twice As Much Out Of Pocket for Prescriptions Compared to Employer Plans

PhRMA  |  Press Release

The firm has consulting practices in healthcare, property & casualty insurance, life insurance and financial services, and employee benefits.

Some Health Insurance Exchange Plans Put All Treatments for Certain Diseases on Top Cost-Sharing Tier

PhRMA  |  Blog Post

This report is evidence that for many, that opportunity has not been realized.

Nikhil V. Dhurandhar, PhD

PhRMA  |  Biography

Dhurandhar has received research funding from the NIH, American Diabetes Association, Federal Emergency Management Agency, and other non-profit or commercial funding sources, has published over 100 scientific articles, and book chapters, and served as a mentor or advisor for several students and postdoctoral fellows.

You have reviewed the first 100 results out of 2221. Each page contains 25 results. You're on page 4.

prev 1 2 3 4 5 6 next